Kevin Gillinder

Kevin Gillinder is an experienced bioinformatician currently working at Laverock Therapeutics since February 2022, focusing on next-generation programmable cell therapies. In addition to this role, Kevin serves as a Research Fellow at The University of Queensland since November 2020, having previously held Research Fellow positions at Monash University and Mater Research from 2017 to 2020 and 2012 to 2017, respectively. Early career experience includes roles as a Research Officer and Senior Research Officer at Mater Research and as a Research Assistant at Newcastle University and The University of Queensland. Kevin holds a Ph.D. in Stem Cells from Newcastle University and has completed a Bachelor of Science with Honors and a Bachelor of Science in Biochemistry at The University of Queensland.